These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34168722)

  • 1. Role of novel biomarkers in diabetic cardiomyopathy.
    Kumric M; Ticinovic Kurir T; Borovac JA; Bozic J
    World J Diabetes; 2021 Jun; 12(6):685-705. PubMed ID: 34168722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Echocardiography in Diabetic Cardiomyopathy: From Mechanisms to Clinical Practice.
    Urlic H; Kumric M; Vrdoljak J; Martinovic D; Dujic G; Vilovic M; Ticinovic Kurir T; Bozic J
    J Cardiovasc Dev Dis; 2023 Jan; 10(2):. PubMed ID: 36826542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Circulating Biomarkers in Diabetic Cardiomyopathy.
    Ianoș RD; Cozma A; Lucaciu RL; Hangan AC; Negrean V; Mercea DC; Ciulei G; Pop C; Procopciuc LM
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review.
    Yin Z; Chen C
    J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy.
    Galis P; Bartosova L; Farkasova V; Bartekova M; Ferenczyova K; Rajtik T
    Front Endocrinol (Lausanne); 2024; 15():1451100. PubMed ID: 39140033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic cardiomyopathy: Clinical phenotype and practice.
    Zhao X; Liu S; Wang X; Chen Y; Pang P; Yang Q; Lin J; Deng S; Wu S; Fan G; Wang B
    Front Endocrinol (Lausanne); 2022; 13():1032268. PubMed ID: 36568097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic approaches for diabetic cardiomyopathy.
    Lorenzo-Almorós A; Tuñón J; Orejas M; Cortés M; Egido J; Lorenzo Ó
    Cardiovasc Diabetol; 2017 Feb; 16(1):28. PubMed ID: 28231848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Serum Biomarkers in Early Detection of Diabetic Cardiomyopathy in the West Virginian Population.
    Shaver A; Nichols A; Thompson E; Mallick A; Payne K; Jones C; Manne ND; Sundaram S; Shapiro JI; Sodhi K
    Int J Med Sci; 2016; 13(3):161-8. PubMed ID: 26941576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy.
    Tao L; Huang X; Xu M; Qin Z; Zhang F; Hua F; Jiang X; Wang Y
    Mol Cell Endocrinol; 2020 Dec; 518():110944. PubMed ID: 32717421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential biomarkers for diabetic cardiomyopathy using LC-MS-based metabolomics.
    Xiong RQ; Li YP; Lin LP; Yao JY
    Endocr Connect; 2024 Mar; 13(3):. PubMed ID: 38180052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathy.
    Abdel Rhman M; Owira P
    J Pharm Pharmacol; 2022 Nov; 74(12):1663-1676. PubMed ID: 36130185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of subclinical diabetic cardiomyopathy by speckle-tracking imaging.
    Minciună IA; Hilda Orășan O; Minciună I; Lazar AL; Sitar-Tăut AV; Oltean M; Tomoaia R; Puiu M; Sitar-Tăut DA; Pop D; Cozma A
    Eur J Clin Invest; 2021 Apr; 51(4):e13475. PubMed ID: 33326612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.
    Deng J; Liao Y; Liu J; Liu W; Yan D
    Front Cell Dev Biol; 2021; 9():777258. PubMed ID: 35004678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
    Zaveri MP; Perry JC; Schuetz TM; Memon MD; Faiz S; Cancarevic I
    Cureus; 2020 Oct; 12(10):e11100. PubMed ID: 33240696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential clinical biomarkers and perspectives in diabetic cardiomyopathy.
    Deng J; Yan F; Tian J; Qiao A; Yan D
    Diabetol Metab Syndr; 2023 Mar; 15(1):35. PubMed ID: 36871006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.
    Dziewięcka E; Winiarczyk M; Wiśniowska-Śmiałek S; Karabinowska-Małocha A; Robak J; Kaciczak M; Baranowski F; Rubiś P
    Cardiology; 2023; 148(5):395-401. PubMed ID: 37311443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate Clinical Characteristics and Prognosis of HFpEF versus HFrEF Phenotype of Diabetic Cardiomyopathy.
    Li Z; Shi Y; Xia Y; Wu L; Li H; Zhou R; Gao X; Zhang H; Jin X; Zhang J
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.
    Liu X; Liu S
    Biomed Rep; 2017 Feb; 6(2):140-145. PubMed ID: 28357065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.